Topical formulation for skin care
AssigneeAesthetics Biomedical, Inc.
InventorFarhan Taghizadeh
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a method of preparing a subject's cells for topical treatment of a subject in need. Also provided is a topical formulation and methods of treating a subject suffering a skin disorder and pain using the topical formulation. Also disclosed herein are devices and systems for micronizing an aspirate in preparation of such a topical formulation.
Claims18
A method of diminishing pore size, red areas or porphyrins on a subject's skin, the method consisting of:
- applying a topical formulation to the skin of the subject to improve the pore size, the red areas or the porphyrins on the skin of the subject, the topical formulation consisting of a pharmaceutical vehicle combined with dermal fibroblasts obtained from the subject and grown in a growth medium consisting of minimum essential medium (MEM) and 5% to 10% v/v human platelet lysate.
A method of diminishing pore size, red areas, bacteria damage or porphyrins in a subject, the method consisting of:
- obtaining dermal fibroblasts from the skin of the subject;
- growing the dermal fibroblasts in a growth medium consisting of a culture medium and 5% to 10% v/v human platelet lysate;
- combining the grown dermal fibroblasts and a pharmaceutical vehicle to form a topical formulation;
- and
- providing the topical formulation to the subject to treat the skin condition,
- wherein the culture medium is selected from the group consisting of alpha-minimum essential medium (MEM), Dulbecco's Modified Eagle's Medium (DMEM) and DMEM/F-12.
A method of diminishing pore size, bacteria damage, or red areas in a subject, the method consisting of:
- applying to the skin of the subject suffering from enlarged pore size, bacteria damage, or red areas a topical formulation consisting of dermal fibroblasts grown in a growth medium consisting of minimum essential medium (MEM) supplemented with 10% human platelet lysate,
- wherein the applying the topical formulation comprises spreading the topical formulation on the forehead, undereye area, cheeks, nose or chin, and
- wherein the applying is performed twice per day for twenty days.
Dependencies are inferred from the claim text.